These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11288794)

  • 1. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial.
    Rocha M; Nava LE; Vázquez de la Torre C; Sánchez-Márin F; Garay-Sevilla ME; Malacara JM
    J Periodontol; 2001 Feb; 72(2):204-9. PubMed ID: 11288794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial.
    Rocha ML; Malacara JM; Sánchez-Marin FJ; Vazquez de la Torre CJ; Fajardo ME
    J Periodontol; 2004 Dec; 75(12):1579-85. PubMed ID: 15732857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis.
    Jeffcoat MK; Cizza G; Shih WJ; Genco R; Lombardi A
    J Int Acad Periodontol; 2007 Jul; 9(3):70-6. PubMed ID: 17715838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.
    Ravn P; Hosking D; Thompson D; Cizza G; Wasnich RD; McClung M; Yates AJ; Bjarnason NH; Christiansen C
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2363-8. PubMed ID: 10404804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
    Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial).
    El-Shinnawi UM; El-Tantawy SI
    J Int Acad Periodontol; 2003 Jan; 5(1):5-10. PubMed ID: 12666950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial.
    Pradeep AR; Sharma A; Rao NS; Bajaj P; Naik SB; Kumari M
    J Periodontol; 2012 Oct; 83(10):1322-8. PubMed ID: 22264208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
    Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.
    Gertz BJ; Clemens JD; Holland SD; Yuan W; Greenspan S
    Calcif Tissue Int; 1998 Aug; 63(2):102-6. PubMed ID: 9685512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
    Saag K; Lindsay R; Kriegman A; Beamer E; Zhou W
    Bone; 2007 May; 40(5):1238-43. PubMed ID: 17347063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group.
    Pols HA; Felsenberg D; Hanley DA; Stepán J; Muñoz-Torres M; Wilkin TJ; Qin-sheng G; Galich AM; Vandormael K; Yates AJ; Stych B
    Osteoporos Int; 1999; 9(5):461-8. PubMed ID: 10550467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topical application of 1% sodium alendronate gel in the surgical treatment of periodontal intrabony defects: A 6-month randomized controlled clinical trial.
    Carvalho Dutra B; Oliveira AMSD; Oliveira PAD; Miranda Cota LO; Silveira JO; Costa FO
    J Periodontol; 2019 Oct; 90(10):1079-1087. PubMed ID: 31071760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alendronate on the progression of periodontitis induced by Porphyromonas gingivalis and Fusobacterium nucleatum: a study in rats.
    Storrer CLM; Deliberador TM; Giovanini AF; Crivellaro V; Zielak JC; Romito GA
    Clin Oral Investig; 2016 Dec; 20(9):2565-2573. PubMed ID: 26955836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial.
    Keegan TH; Schwartz AV; Bauer DC; Sellmeyer DE; Kelsey JL;
    Diabetes Care; 2004 Jul; 27(7):1547-53. PubMed ID: 15220226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study.
    Hosking D; Adami S; Felsenberg D; Andia JC; Välimäki M; Benhamou L; Reginster JY; Yacik C; Rybak-Feglin A; Petruschke RA; Zaru L; Santora AC
    Curr Med Res Opin; 2003; 19(5):383-94. PubMed ID: 13678475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial.
    Sharma A; Pradeep AR
    J Periodontol; 2012 Jan; 83(1):11-8. PubMed ID: 21542734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of alendronate in postmenopausal type 2 diabetes mellitus.
    Ikeda T; Manabe H; Iwata K
    Diabetes Metab; 2004 Sep; 30(4):355-8. PubMed ID: 15525879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and tolerability of alendronate in postmenopausal osteoporotic Chinese women: a randomized placebo-controlled study.
    Kung AW; Yeung SS; Chu LW
    Calcif Tissue Int; 2000 Oct; 67(4):286-90. PubMed ID: 11000341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.